Evercore ISI downgraded Thorne HealthTech to In Line from Outperform with a price target of $10.20, up from $8, after L Catterton agreed to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on THRN:
- Thorne HealthTech downgraded to Market Perform from Outperform at TD Cowen
- Thorne HealthTech downgraded to Hold from Buy at Canaccord
- Thorne HealthTech (NASDAQ:THRN) Soars on Acquisition News; Company Going Private
- Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
- Thorne HealthTech to be acquired by L Catterton for $10.20 per share in cash